Lab Bivona

December 13, 2017

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers

Lab Bivona

December 13, 2017

Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709185/"target="_blank

Newer PostOncogenic Signaling Pathways in The Cancer Genome Atlas.

Older PostEfficacy of SHP2 phosphatase inhibition in cancers with nucleotide-cycling oncogenic RAS, RAS-GTP dependent oncogenic BRAF and NF1 loss